Mineralys Therapeutics, Inc.
MLYS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001933414
In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Mineralys Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 94 | 1 | 106 | +13 |
| Shares | 44.2M | 2.05M | 44.4M | +2.28M (+5.4%) |
| Value | $516.6M | $23.9M | $540.1M | +$47.4M (+9.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 2,144,168 | $26.0M | 0.00% |
| Integral Health Asset Management, LLC | 356,000 | $4.31M | 0.51% |
| Ikarian Capital, LLC | 180,000 | $2.18M | 0.68% |
| Wellington Management Group LLP | 63,998 | $775.0K | 0.00% |
| Polar Asset Management Partners Inc. | 40,500 | $490.5K | 0.01% |
| Squarepoint Ops LLC | 20,505 | $248.3K | 0.00% |
| Martingale Asset Management L P | 14,965 | $181.2K | 0.00% |
| PDT Partners, LLC | 12,238 | $148.2K | 0.01% |
| Algert Global LLC | 11,196 | $135.6K | 0.00% |
| SG Americas Securities, LLC | 9,116 | $110.0K | 0.00% |
| GeoWealth Management, LLC | 1,439 | $17.4K | 0.00% |
| Acadian Asset Management LLC | 1,472 | $17.0K | 0.00% |
| Quest Partners LLC | 556 | $6.73K | 0.00% |
| Simplex Trading, LLC | 304 | $3.00K | 0.00% |
| Sterling Capital Management LLC | 77 | $932 | 0.00% |
| GAMMA Investing LLC | 75 | $908 | 0.00% |
| Voisard Asset Management Group, Inc. | 30 | $364 | 0.00% |
| Bokf, NA | 25 | $323 | 0.00% |
| Capital Performance Advisors LLP | 23 | $279 | 0.00% |
Sold out (6)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Rock Springs Capital Management LP | 378,932 | $4.43M |
| ExodusPoint Capital Management, LP | 274,316 | $3.21M |
| Driehaus Capital Management LLC | 257,371 | $3.01M |
| Two Sigma Investments, LP | 16,134 | $188.8K |
| EntryPoint Capital, LLC | 7,956 | $93.1K |
| Advisor Group Holdings, Inc. | 100 | $1.17K |
Not filed for Q3 2024 yet (1)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 2,045,702 | $23.9M |